Factors Behind Tilray Stock Increase This Week

Shares of Tilray Brands (NASDAQ: TLRY) experienced a 65% increase this past week, driven by investor optimism regarding potential regulatory changes in the cannabis industry. Reports indicate that President Trump is considering reclassifying marijuana from a Schedule I to a Schedule III drug, which could alleviate strict regulations. A decision on this matter is expected as early as Monday, December 15, according to The Washington Post.

Want More Context? 🔎